Huntsman (HUN) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Revenues for Q3 2025 declined 5% year-over-year to $1.46 billion, with a net loss of $25 million, an improvement from a $33 million loss in Q3 2024; adjusted EBITDA was $94 million, down from $131 million.
Free cash flow from continuing operations improved to $157 million from $93 million year-over-year, with strong cash generation attributed to working capital and capex control.
Dividend reduced by 65% to $0.0875 per share quarterly ($0.35 annualized), freeing up $115 million in cash and preserving balance sheet strength.
Aggressive cost and cash management continues, with a $100 million cost reduction program on track, including 600 position eliminations and multiple site closures.
Facing unprecedented macro challenges in the U.S., China, and Europe, including inflation, weak consumer demand, and deindustrialization pressures.
Financial highlights
Q3 2025 revenue: $1.46 billion (down 5% year-over-year); adjusted EBITDA: $94 million (down 28%); net loss: $25 million.
Free cash flow for nine months: $105 million; operating cash flow for Q3: $200 million.
Net debt at quarter-end: $1.54 billion; liquidity of $1.4 billion.
Dividend cash requirement for 2026 set at $60 million, down from $175 million.
Adjusted EBITDA margin for Q3 2025 was 6%, down from 9% in Q3 2024.
Outlook and guidance
4Q25 adjusted EBITDA expected between $25 million and $50 million, with continued market challenges and seasonal volume declines anticipated.
Cost savings program expected to deliver $100 million in run-rate benefits by end of 2026, with $75 million benefit in 2025.
Capital expenditures for 2025 projected at $170–$180 million, funded by operating cash flow.
Too early to forecast 2026; expect typical Q4 seasonality with higher-than-average destocking, especially in Europe.
Incremental EBITDA upside in 2026 expected from new product introductions, business turnarounds, and contract wins.
Latest events from Huntsman
- Olin and Huntsman shareholders to vote on a merger of equals, forming OlinHuntsman Corporation.HUN
Proxy filing13 Jul 2026 - Q4 2024 saw revenue growth and improved EBITDA, but net loss and restructuring persist.HUN
Q4 20249 Jul 2026 - Q2 2024 saw lower revenue and EBITDA, higher net income, and 9% sales volume growth.HUN
Q2 202430 Jun 2026 - $12B+ all-stock merger creates a chemicals leader with $400M+ synergies, closing H1 2027.HUN
M&A announcement16 Jun 2026 - $12B+ merger forms a chemicals leader with $400M+ synergies and balanced governance.HUN
Investor presentation16 Jun 2026 - Board elections, compensation, and auditor ratified; independent chair proposal rejected.HUN
AGM 202615 May 2026 - Net loss widened to $53M on flat revenue, with Advanced Materials outperforming other segments.HUN
Q1 20261 May 2026 - Board urges support for all director nominees, highlighting Mr. Muñoz’s strategic value despite attendance concerns.HUN
Proxy filing20 Apr 2026 - Annual meeting covers director elections, say-on-pay, auditor ratification, and governance proposal.HUN
Proxy Filing16 Mar 2026